Glenview Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-195,585
Closed -$62.8M 53
2024
Q2
$62.8M Hold
195,585
1.24% 23
2024
Q1
$65.2M Sell
195,585
-55,931
-22% -$17.1M 1.14% 26
2023
Q4
$68.1M Sell
251,516
-78,943
-24% -$19.5M 1.46% 20
2023
Q3
$81.3M Buy
330,459
+66,835
+25% +$18.3M 1.84% 19
2023
Q2
$80M Sell
263,624
-188,603
-42% -$52.4M 1.8% 18
2023
Q1
$119M Buy
452,227
+12,242
+3% +$3.11M 2.62% 11
2022
Q4
$106M Buy
439,985
+123,156
+39% +$27.6M 2.34% 12
2022
Q3
$58.2M Hold
316,829
1.46% 19
2022
Q2
$53.2M Hold
316,829
1.33% 22
2022
Q1
$79.4M Sell
316,829
-162,451
-34% -$40.8M 1.61% 22
2021
Q4
$123M Sell
479,280
-45,957
-9% -$11.2M 2.62% 10
2021
Q3
$127M Sell
525,237
-141,698
-21% -$34.6M 2.31% 13
2021
Q2
$138M Sell
666,935
-403,525
-38% -$82.2M 2.28% 12
2021
Q1
$202M Sell
1,070,460
-229,721
-18% -$40.5M 3.42% 8
2020
Q4
$214M Sell
1,300,181
-338,334
-21% -$49.5M 4.9% 6
2020
Q3
$204M Sell
1,638,515
-518,694
-24% -$64.2M 6.41% 5
2020
Q2
$209M Sell
2,157,209
-655,472
-23% -$68.1M 5.77% 5
2020
Q1
$253M Sell
2,812,681
-3,152,172
-53% -$408M 6.87% 5
2019
Q4
$882M Buy
5,964,853
+624,137
+12% +$83.8M 7.72% 1
2019
Q3
$643M Buy
5,340,716
+292,650
+6% +$37.8M 6.77% 2
2019
Q2
$682M Buy
5,048,066
+804,562
+19% +$102M 6.18% 2
2019
Q1
$553M Sell
4,243,504
-655,065
-13% -$88M 4.94% 6
2018
Q4
$610M Buy
4,898,569
+563,467
+13% +$75.6M 5.9% 4
2018
Q3
$603M Sell
4,335,102
-997,821
-19% -$124M 3.83% 7
2018
Q2
$547M Sell
5,332,923
-6,526,669
-55% -$660M 3.73% 9
2018
Q1
$1.15B Sell
11,859,592
-491,530
-4% -$47.7M 6.73% 1
2017
Q4
$1.08B Sell
12,351,122
-2,804,820
-19% -$225M 5.86% 1
2017
Q3
$1.21B Buy
15,155,942
+256,653
+2% +$20.6M 7% 1
2017
Q2
$1.3B Buy
14,899,289
+634,024
+4% +$53.6M 8.43% 1
2017
Q1
$1.27B Sell
14,265,265
-3,916,176
-22% -$327M 8.42% 1
2016
Q4
$1.35B Buy
18,181,441
+2,192,451
+14% +$164M 9.1% 1
2016
Q3
$1.21B Buy
15,988,990
+1,401,998
+10% +$107M 8.65% 2
2016
Q2
$1.12B Sell
14,586,992
-88,600
-0.6% -$6.99M 7.94% 2
2016
Q1
$1.15B Buy
14,675,592
+375,043
+3% +$26.2M 8.37% 2
2015
Q4
$967M Buy
14,300,549
+8,787,271
+159% +$613M 5.45% 4
2015
Q3
$427M Buy
5,513,278
+334,700
+6% +$29.6M 2.12% 17
2015
Q2
$470M Sell
5,178,578
-100
-0% -$8.01K 1.86% 17
2015
Q1
$390M Sell
5,178,678
-1,000,000
-16% -$71.8M 1.78% 20
2014
Q4
$453M Sell
6,178,678
-3,431,881
-36% -$241M 2.27% 14
2014
Q3
$678M Sell
9,610,559
-2,252,083
-19% -$149M 3.54% 5
2014
Q2
$669M Sell
11,862,642
-979,071
-8% -$51.7M 3.87% 4
2014
Q1
$674M Hold
12,841,713
4.42% 3
2013
Q4
$613M Buy
12,841,713
+2,500,000
+24% +$116M 4.39% 2
2013
Q3
$442M Buy
10,341,713
+500,000
+5% +$19.5M 3.72% 5
2013
Q2
$355M Buy
+9,841,713
New +$381M 3.25% 10

Other funds holding HCA

Glenview Capital Management's HCA Position: Q3 2024 in Review

Glenview Capital Management sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 195,585 shares — an estimated $62.8M sold.

Glenview Capital Management first reported a position in HCA in Q2 2013 and held it in 45 quarters. The position peaked at $1.35B in Q4 2016. 1,203 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • Glenview Capital Management reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
  • Glenview Capital Management sold 195,585 HCA Healthcare shares in Q3 2024, an estimated $62.8M.
  • Glenview Capital Management first reported a position in HCA Healthcare in Q2 2013 and held it in 45 quarters.
  • Glenview Capital Management's HCA Healthcare position peaked at $1.35B in Q4 2016.
  • 1,203 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on Glenview Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.